What Have We Learnt About the Treatment of Juvenile-Onset Systemic Lupus Erythematous Since Development of the SHARE Recommendations 2012?

Front Pediatr · 2022 · PMC9047745 · PMID 35498799

Europe PMC DOI

hedged sentence

0.2800

closest p · 5.6× alpha

0.2800

boldest claim

The sentences

did not reach statistical significancep = 0.28not close (p > 0.1)

There was a numerical difference in the proportion of patients achieving complete remission (76.5% achieved complete remission with rituximab, 41.7% with MMF and 46.7% with cyclophosphamide, however this did not reach statistical significance ( p = 0.28, Table 3 ) ( 48 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.